{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:11Z","timestamp":1792783511220,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen","id":[{"id":"https:\/\/ror.org\/05591te55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The socio-occupational burden of Cushing\u2019s syndrome (CS) remains underrecognised. In clinical practice, surgically treated patients are often considered recovered, potentially overlooking persistent impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate work ability, social and employment status in newly diagnosed and remitted CS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>National observational study with two arms: a monocentric prospective study of patients evaluated for suspected endogenous glucocorticoid excess (cohort 1), and a multicenter cross-sectional study of patients in remission from CS, comparing those with recovered versus persistent adrenal insufficiency (cohort 2). All participants underwent standardised assessments and completed validated questionnaires on socioeconomic status, work ability, and fatigue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In cohort 1, individuals with active CS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928) and excluded CS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956) had comparable comorbidities, education, and employment. However, work ability scores were lower in active CS (median 22.5 vs. 28.5,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) and correlated inversely with biochemical cortisol excess. In multivariable analyses, active CS and depression were independently associated with lower work ability, whereas older age and depression were independently associated with fatigue severity. In cohort 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200989, 39 with recovered, 50 with persistent adrenal insufficiency), overall employment was 69%. Poor work ability was common (42% with recovered vs. 58% with persistent adrenal insufficiency) and weekly working hours were lower in those with persistent insufficiency (33\u00a0h vs. 39\u00a0h,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.051). Overall, illness-related absences occurred in 76% during the preceding year, disability was recognised in 47%, and 15% received reduced earning capacity pensions. Fatigue correlated negatively with work ability (\n                      <jats:italic>r<\/jats:italic>\n                      = \u2212 0.73,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is an unmet need for structured rehabilitation and reintegration in CS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02966-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:47:04Z","timestamp":1783511224000},"page":"2721-2734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low work ability and high disability burden in Cushing\u2019s syndrome: a multicenter cohort study"],"prefix":"10.1007","volume":"49","author":[{"given":"Annika","family":"Steinkogler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fania R. O. L.","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"St\u00fcfchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"V\u00f6lter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ritzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marily","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Linkohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Kienitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7323-9085","authenticated-orcid":false,"given":"Elisabeth","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"2","key":"2966_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke M, Fleseriu M (2023) Cushing Syndrome: A Review. JAMA 330(2):170\u2013181","journal-title":"JAMA"},{"issue":"5","key":"2966_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-19-0464","volume":"181","author":"E Valassi","year":"2019","unstructured":"Valassi E, Tabarin A, Brue T, Feelders RA, Reincke M, Netea-Maier R et al (2019) High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN registry. Eur J Endocrinol 181(5):461\u2013472","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2966_CR3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"Ragnarsson O, Olsson DS, Papakokkinou E, Chantzichristos D, Dahlqvist P, Segerstedt E et al (2019) Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study. J Clin Endocrinol Metab 104(6):2375\u20132384","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2966_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","volume":"4","author":"RN Clayton","year":"2016","unstructured":"Clayton RN, Jones PW, Reulen RC, Stewart PM, Hassan-Smith ZK, Ntali G et al (2016) Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol 4(7):569\u2013576","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10418","key":"2966_CR5","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet 402(10418):2237\u20132252","journal-title":"Lancet"},{"issue":"8","key":"2966_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S2213-8587(23)00150-X","volume":"11","author":"E Nowak","year":"2023","unstructured":"Nowak E, Vogel F, Albani A, Braun L, Rubinstein G, Zopp S et al (2023) Diagnostic challenges in cyclic Cushing\u2019s syndrome: a systematic review. Lancet Diabetes Endocrinol 11(8):593\u2013606","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2966_CR7","doi-asserted-by":"publisher","unstructured":"Braun LT, Vogel F, Rubinstein G, Zopp S, Nowak E, Constantinescu G et al (2023) Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation. Eur J Endocrinol. 188(1):59\u201366 https:\/\/doi.org\/10.1093\/ejendo\/lvac016","DOI":"10.1093\/ejendo\/lvac016"},{"key":"2966_CR8","doi-asserted-by":"crossref","unstructured":"Nowak EZQ, Zhang S, Zhao Y, Ye H, Machado MC, Santiago Moises CC, T\u00f3th M, Stark JYK, Gurnell M, MacFarlane J, McCormack A, Govinna M, Gilis, Januszewska AMM, Bonaventura I, Czepielewski MA, Ferriere A, Gadelha M, Isidori AMKD, Maiter D, Tabarin A, Alexandraki KI, Chang J, Frontera ED, Hanzu FAMN, Miljic D, Pichler R, Popovic V, Spencer-Segal JL, Tordjman K, AkirovA A-CM, Arvat E, Bancos I, Bioletto F, Burman P, Castinetti F, Detomas M et al (2025) Cycle characterisation and clinical complications in patients with cyclic Cushing\u2019s syndrome: insights from an international retrospective cohort study. Lancet Diabetes Endocrinol","DOI":"10.1016\/S2213-8587(25)00249-9"},{"issue":"2","key":"2966_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/ejendo\/lvae097","volume":"191","author":"E Nowak","year":"2024","unstructured":"Nowak E, Vogel F, Braun L, Zopp S, Rubinstein G, Schilbach K et al (2024) Prevalence and outcome of secondary hypogonadism in male patients with Cushing\u2019s syndrome and mild autonomous cortisol secretion. Eur J Endocrinol 191(2):232\u2013240","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2966_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ejendo\/lvad041","volume":"188","author":"F Vogel","year":"2023","unstructured":"Vogel F, Braun L, Zopp S, Nowak E, Schreiner J, Benz I et al (2023) Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing\u2019s syndrome. Eur J Endocrinol 188(4):375\u2013384","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2966_CR11","doi-asserted-by":"publisher","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","volume":"97","author":"O Ragnarsson","year":"2012","unstructured":"Ragnarsson O, Berglund P, Eder DN, Johannsson G (2012) Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission. J Clin Endocrinol Metab 97(9):E1640\u2013E1648","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2966_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11102-022-01245-9","volume":"25","author":"SM Webb","year":"2022","unstructured":"Webb SM, Valassi E (2022) Quality of life impairment after a diagnosis of Cushing\u2019s syndrome. Pituitary 25(5):768\u2013771","journal-title":"Pituitary"},{"issue":"5","key":"2966_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","volume":"245","author":"L Pikkarainen","year":"1999","unstructured":"Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing\u2019s syndrome. J Intern Med 245(5):463\u2013468","journal-title":"J Intern Med"},{"issue":"5","key":"2966_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-12-0308","volume":"167","author":"MA Wagenmakers","year":"2012","unstructured":"Wagenmakers MA, Netea-Maier RT, Prins JB, Dekkers T, den Heijer M, Hermus AR (2012) Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur J Endocrinol 167(5):687\u2013695","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2966_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11102-018-0913-3","volume":"21","author":"DJ Lobatto","year":"2018","unstructured":"Lobatto DJ, Steffens ANV, Zamanipoor Najafabadi AH, Andela CD, Pereira AM, van den Hout WB et al (2018) Work disability and its determinants in patients with pituitary tumor-related disease. Pituitary 21(6):593\u2013604","journal-title":"Pituitary"},{"issue":"3","key":"2966_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P et al (2011) The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383\u2013392","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2966_CR17","doi-asserted-by":"publisher","first-page":"e2921","DOI":"10.1210\/clinem\/dgac174","volume":"107","author":"A Ebbehoj","year":"2022","unstructured":"Ebbehoj A, Sondergaard E, Jepsen P, Stochholm K, Svane HML, Madsen M et al (2022) The Socioeconomic Consequences of Cushing\u2019s Syndrome: A Nationwide Cohort Study. J Clin Endocrinol Metab 107(7):e2921\u2013e9","journal-title":"J Clin Endocrinol Metab"},{"key":"2966_CR18","doi-asserted-by":"publisher","unstructured":"Rubinstein G, Osswald A, Hoster E, Losa M, Elenkova A, Zacharieva S et al (2020) Time to Diagnosis in Cushing\u2019s Syndrome: A Meta-Analysis Based on 5367 Patients. J Clin Endocrinol Metab. 105(3):e12\u2013e22 https:\/\/doi.org\/10.1210\/clinem\/dgz136","DOI":"10.1210\/clinem\/dgz136"},{"issue":"3","key":"2966_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/ejendo\/lvaf021","volume":"192","author":"D Bengtsson","year":"2025","unstructured":"Bengtsson D, Jaras J, Burman P, Wahlberg J, Ragnarsson O (2025) Socioeconomic status and its association with outcome in patients with Cushing\u2019s disease. Eur J Endocrinol 192(3):159\u2013169","journal-title":"Eur J Endocrinol"},{"key":"2966_CR20","unstructured":"Versorgungsmedizin-Verordnung vom 10. Dezember 2008 (BGBl. I S. 2412), die zuletzt durch Artikel 1 der Verordnung vom 29. September 2025 (BGBl. 2025 I Nr. 228) ge\u00e4ndert worden ist, available online at: https:\/\/www.gesetze-im-internet.de\/versmedv\/BJNR241200008.html?utm_"},{"issue":"12","key":"2966_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2966_CR22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2966_CR23","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A et al (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"2966_CR24","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1055\/s-2005-858235","volume":"67","author":"R Holle","year":"2005","unstructured":"Holle R, Happich M, Lowel H, Wichmann HE, Group MKS (2005) KORA\u2013a research platform for population based health research. Gesundheitswesen 67(Suppl 1):S19\u201325","journal-title":"Gesundheitswesen"},{"key":"2966_CR25","doi-asserted-by":"publisher","unstructured":"Linkohr B, Heier M, Gieger C, Thorand B, Grallert H, Holle R et al (2025) Cohort Profile: Cooperative Health Research in the Region of Augsburg (KORA) 1984\u20132024. Int J Epidemiol. 54(6) https:\/\/doi.org\/10.1093\/ije\/dyaf187","DOI":"10.1093\/ije\/dyaf187"},{"key":"2966_CR26","volume-title":"Der Work Ability Index. Ein Leitfaden (Schriftenreihe der Bundesanstalt f\u00fcr Arbeitsschutz und Arbeitsmedizin: Sonderschrift","author":"HMF Hasselhorn","year":"2007","unstructured":"Hasselhorn HMF (2007) G. Der Work Ability Index. Ein Leitfaden (Schriftenreihe der Bundesanstalt f\u00fcr Arbeitsschutz und Arbeitsmedizin: Sonderschrift, vol 87. Verlag f\u00fcr neue Wissenschaft, Bremerhaven"},{"key":"2966_CR27","unstructured":"INQA-WAI-Netzwerk (2017) Wie steht es um Ihre Arbeitsf\u00e4higkeit? WAI*-Fragebogen & Auswertung (Kurzversion). URL: https:\/\/www.wainetzwerk.de\/uploads\/content\/pdf\/WAI-Fragebogen-Kurzversion%20mit%20Auswertungsbogen.pdf (accessed on Oct 1 2023)"},{"issue":"11","key":"2966_CR28","first-page":"1450","volume":"17","author":"LB Krupp","year":"1990","unstructured":"Krupp LB, LaRocca NG, Muir J, Steinberg AD (1990) A study of fatigue in systemic lupus erythematosus. J Rheumatol 17(11):1450\u20131452","journal-title":"J Rheumatol"},{"issue":"10","key":"2966_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121\u20131123","journal-title":"Arch Neurol"},{"issue":"10","key":"2966_CR30","first-page":"403","volume":"52","author":"LB Krupp","year":"1991","unstructured":"Krupp LB, Mendelson WB, Friedman R (1991) An overview of chronic fatigue syndrome. J Clin Psychiatry 52(10):403\u2013410","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2966_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1530\/EJE-16-0689","volume":"176","author":"CM Berr","year":"2017","unstructured":"Berr CM, Stieg MR, Deutschbein T, Quinkler M, Schmidmaier R, Osswald A et al (2017) Persistence of myopathy in Cushing\u2019s syndrome: evaluation of the German Cushing\u2019s Registry. Eur J Endocrinol 176(6):737\u2013746","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2966_CR32","doi-asserted-by":"publisher","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","volume":"105","author":"F Vogel","year":"2020","unstructured":"Vogel F, Braun LT, Rubinstein G, Zopp S, Kunzel H, Strasding F et al (2020) Persisting Muscle Dysfunction in Cushing\u2019s Syndrome Despite Biochemical Remission. J Clin Endocrinol Metab 105(12):e4490\u2013e4498","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2966_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ejendo\/lvae069","volume":"191","author":"S Germann","year":"2024","unstructured":"Germann S, Wimmer R, Laager R, Mueller B, Schuetz P, Kaegi-Braun N et al (2024) Long-term outcomes in patients with Cushing\u2019s disease vs nonfunctioning pituitary adenoma after pituitary surgery: an active-comparator cohort study. Eur J Endocrinol 191(1):97\u2013105","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2966_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1055\/a-1217-7208","volume":"129","author":"T Kienitz","year":"2021","unstructured":"Kienitz T, Hahner S, Burger-Stritt S, Quinkler M (2021) Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions. Exp Clin Endocrinol Diabetes 129(3):241\u2013249","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"2966_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2014-3191","volume":"100","author":"S Hahner","year":"2015","unstructured":"Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407\u2013416","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2966_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/ejendo\/lvaf022","volume":"192","author":"S Stergianos","year":"2025","unstructured":"Stergianos S, Everhov AH, Soderling J, Bergthorsdottir R, Wahlberg J, Skov J et al (2025) Income and work loss in patients with Addison\u2019s disease: a nationwide population-based study. Eur J Endocrinol 192(3):170\u2013179","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2966_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","volume":"339","author":"B Bleicken","year":"2010","unstructured":"Bleicken B, Hahner S, Ventz M, Quinkler M (2010) Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci 339(6):525\u2013531","journal-title":"Am J Med Sci"},{"key":"2966_CR38","doi-asserted-by":"crossref","unstructured":"Valassi E, Chiodini I, Feelders RA, Andela CD, Abou-Hanna M, Idres S et al (2022) Unmet needs in Cushing\u2019s syndrome: the patients\u2019 perspective. Endocr Connect. ;11(7)","DOI":"10.1530\/EC-22-0027"},{"issue":"5","key":"2966_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s11102-024-01450-8","volume":"27","author":"EB Geer","year":"2024","unstructured":"Geer EB, Grillo I, Li Q, Robins H, Cohen V, Baratz H et al (2024) Sleep disruption in patients with active and treated endogenous Cushing\u2019s syndrome. Pituitary 27(5):654\u2013664","journal-title":"Pituitary"},{"key":"2966_CR40","doi-asserted-by":"publisher","first-page":"103412","DOI":"10.1016\/j.eclinm.2025.103412","volume":"87","author":"C Tan","year":"2025","unstructured":"Tan C, Meng J, Dai X, He B, Liu P, Wu Y et al (2025) Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials. EClinicalMedicine 87:103412","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02966-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:57Z","timestamp":1790757237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02966-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2966"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02966-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.N. serves as an associate editor of the\n                      Journal of Endocrinological Investigation\n                      but was not involved in the review or editorial decision-making process for this manuscript. E.N. reports speaker\u2019s and advisory board honoraria from Esteve. M.R. reports speaker\u2019s honoraria and consulting by Novartis, Pfizer, Recordati Rare Disease, Ipsen, HRA Pharma, Crinetics, Lundbeck.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"0000-0002-7323-9085.","order":2,"name":"Ethics","label":"ORCID-ID","group":{"name":"EthicsHeading","label":"Declarations"}}]}}